Network pharmacology and molecular docking approach to identify the mechanisms and molecular targets of Allium ascalonicum L. extract against atherosclerosis
Journal of Pharmacy & Pharmacognosy Research · 01.03.2026 · 14 (2) · 2528
DOI: 10.56499/jppres_14.2.2528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmacognosy Research, online erschienen am 01.03.2026. Verfasst von Laily Shofiyah und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Context
Atherosclerosis remains a leading cause of mortality globally, and current therapeutic strategies are often insufficient. Allium ascalonicum L. (shallot) has demonstrated cardioprotective effects, but its molecular mechanisms remain inadequately defined.
Aims
To elucidate the molecular mechanisms and potential targets of A. ascalonicum extract in the prevention and treatment of atherosclerosis.
Methods
A network pharmacology and molecular docking approach was employed to investigate the interactions between key bioactive compounds (kaempferol, quercetin, quercetin 3-O-alpha-L-rhamnoside, and allicin) and atherosclerosis-associated proteins.
Results
Target prediction identified 1,644 atherosclerosis-related proteins interacting with A. ascalonicum compounds. Among these, Nrf2 was highlighted as a primary target involved in lipid metabolism, oxidative stress, and inflammation. Molecular docking revealed strong binding affinities between Nrf2 regulators (KEAP1) and bioactive compounds, particularly quercetin 3-O-alpha-L-rhamnoside.
Conclusions
The findings suggest that A. ascalonicum may serve as a potential anti-atherosclerotic agent through modulation of the KEAP1-Nrf2 pathway. These results warrant further experimental validation.
Zitieren
APA
Shofiyah, L., Dirgahayu, P., Pamungkasari, E. P., Nurwati, I., Ardyanto, T. D., Cilmiaty, R., & Febrinasari, R. P. (2026). Network pharmacology and molecular docking approach to identify the mechanisms and molecular targets of Allium ascalonicum L. extract against atherosclerosis. Journal of Pharmacy & Pharmacognosy Research, 14(2), 2528. https://doi.org/10.56499/jppres_14.2.2528
Vancouver
Shofiyah L, Dirgahayu P, Pamungkasari EP, Nurwati I, Ardyanto TD, Cilmiaty R, et al. Network pharmacology and molecular docking approach to identify the mechanisms and molecular targets of Allium ascalonicum L. extract against atherosclerosis. Journal of Pharmacy & Pharmacognosy Research. 2026;14(2):2528. doi:10.56499/jppres_14.2.2528
BibTeX
@article{Shofiyah2026,
author = {Shofiyah, Laily and Dirgahayu, Paramasari and Pamungkasari, Eti P. and Nurwati, Ida and Ardyanto, Tonang D. and Cilmiaty, Risya and Febrinasari, Ratih P.},
title = {Network pharmacology and molecular docking approach to identify the mechanisms and molecular targets of Allium ascalonicum L. extract against atherosclerosis},
journal = {Journal of Pharmacy & Pharmacognosy Research},
year = {2026},
volume = {14},
number = {2},
pages = {2528},
doi = {10.56499/jppres_14.2.2528}
}
EUVIMED